Recurrent Non-small Cell Lung Cancer [clinicaltrials_resource:bb8eda508eb154252f154ebf546adcec]
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu [clinicaltrials:NCT00004074]Trastuzumab in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer That Overexpresses HER2 [clinicaltrials:NCT00004883]Suramin, Paclitaxel, and Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer [clinicaltrials:NCT00006929]FR901228 in Treating Patients With Refractory or Progressive Small Cell Lung Cancer or Non-small Cell Lung Cancer [clinicaltrials:NCT00020202]Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer [clinicaltrials:NCT00021060]Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid Tumors [clinicaltrials:NCT00028535]Gefitinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer [clinicaltrials:NCT00029003]Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction [clinicaltrials:NCT00030498]7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) [clinicaltrials:NCT00031681]Monoclonal Antibody Therapy in Treating Patients With Ovarian Epithelial Cancer, Melanoma, Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Non-Small Cell Lung Cancer [clinicaltrials:NCT00039091]Bortezomib in Treating Patients With Advanced Non-small Cell Lung Cancer [clinicaltrials:NCT00040768]Bortezomib Plus Gemcitabine and Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer [clinicaltrials:NCT00052338]Erlotinib and Celecoxib in Treating Patients With Stage IIIB or Stage IV Recurrent Non-Small Cell Lung Cancer [clinicaltrials:NCT00062101]Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and Neck [clinicaltrials:NCT00063895]Suramin and Either Docetaxel or Gemcitabine in Treating Patients With Stage IIIB or Stage IV Platinum-Refractory Non-Small Cell Lung Cancer [clinicaltrials:NCT00066768]Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer [clinicaltrials:NCT00068497]GTI-2040 and Docetaxel in Treating Patients With Recurrent, Metastatic, or Unresectable Locally Advanced Non-Small Cell Lung Cancer, Prostate Cancer, or Other Solid Tumors [clinicaltrials:NCT00074022]Gemcitabine, Carboplatin, and Bortezomib in Advanced or Recurrent Non-Small Cell Lung Cancer [clinicaltrials:NCT00075751]A Phase II Trial of Triapine (NSC #663249) in Combination With Gemcitabine as Second Line Treatment of Non-Small Cell Lung Cancer [clinicaltrials:NCT00077350]CCI-779 in Treating Patients With Stage IIIB (With Pleural Effusion) or Stage IV Non-Small Cell Lung Cancer [clinicaltrials:NCT00079235]Decitabine and Valproic Acid in Treating Patients With Non-Small Cell Lung Cancer [clinicaltrials:NCT00084981]Erlotinib in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer [clinicaltrials:NCT00085280]EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer [clinicaltrials:NCT00087191]S0341: Erlotinib in Treating Patients With Advanced Primary Non-Small Cell Lung Cancer [clinicaltrials:NCT00087412]Vaccine Therapy and Sargramostim With or Without Docetaxel in Treating Patients With Metastatic Lung Cancer or Metastatic Colorectal Cancer [clinicaltrials:NCT00088933]Celecoxib and Erlotinib in Treating Former Smokers With Stage IIIB or Stage IV Non-Small Cell Lung Cancer [clinicaltrials:NCT00088959]clinicaltrials:NCT00093756clinicaltrials:NCT00096265Sorafenib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer [clinicaltrials:NCT00098540]Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer [clinicaltrials:NCT00101348]clinicaltrials:NCT00118144Docetaxel With Either Cetuximab or Bortezomib as First-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer [clinicaltrials:NCT00118183]clinicaltrials:NCT00126581clinicaltrials:NCT00138203Cyclophosphamide or Denileukin Diftitox Followed By Expanding a Patient's Own T Cells in the Laboratory in Treating Patients With HER-2/Neu Overexpressing Metastatic Breast Cancer, Ovarian Cancer, or Non-Small Cell Lung Cancer Previously Treated With HER-2/Neu Vaccine [clinicaltrials:NCT00228358]clinicaltrials:NCT00245063clinicaltrials:NCT00362882Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer [clinicaltrials:NCT00397384]clinicaltrials:NCT00400829Imatinib Mesylate and Paclitaxel in Treating Older Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer [clinicaltrials:NCT00408460]
condition [clinicaltrials_vocabulary:condition]
Recurrent Non-small Cell Lung Cancer [clinicaltrials_resource:bb8eda508eb154252f154ebf546adcec]
Bio2RDF identifier
bb8eda508eb154252f154ebf546adcec
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:bb8eda508eb154252f154ebf546adcec
identifier
clinicaltrials_resource:bb8eda508eb154252f154ebf546adcec
title
Recurrent Non-small Cell Lung Cancer
@en
label
Recurrent Non-small Cell Lung ...... eda508eb154252f154ebf546adcec]
@en